Literature DB >> 9576864

Complementation studies with co-expressed fragments of human red cell band 3 (AE1): the assembly of the anion-transport domain in xenopus oocytes and a cell-free translation system.

J D Groves1, L Wang, M J Tanner.   

Abstract

We examined the assembly of the membrane domain of the human red cell anion transporter (band 3; AE1) by co-expression of recombinant N- and C-terminal fragments in Xenopus oocytes and in cell-free translation with canine pancreatic microsomes. Co-immunoprecipitation was performed in non-denaturing detergent solutions using antibodies directed against the N- and C-termini of the membrane domain. Eleven of the twelve fragments were expressed stably in oocytes in the presence or absence of their respective partners. However, the fragment containing from putative span nine to the C-terminus could be detected in oocytes only when co-expressed with its complementary partner containing the first eight spans. Co-expression of pairs of fragments divided in the first, second, third and fourth exofacial loops and in the fourth cytoplasmic loop resulted in a concentration-dependent association, but a pair of fragments divided in the sixth cytoplasmic loop did not co-immunoprecipitate. When two complementary fragments were translated separately in the cell-free system and the purified microsomes were then mixed, co-immunoprecipitation was observed only if the membranes were first fused using polyethylene glycol. This shows that co-immunoprecipitation results from specific interactions within the membrane and is not an artefact of detergent solubilization or immunoprecipitation. We demonstrate that band 3 assembly can occur within the membrane after translation, insertion and initial folding of the individual fragments have been completed. We conclude that most band 3 fragments contain the necessary information to fold in the membrane and adopt a structure that is sufficiently similar to the native protein that it permits correct assembly with its complementary partner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576864      PMCID: PMC1219464          DOI: 10.1042/bj3320161

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Bacteriorhodopsin can be refolded from two independently stable transmembrane helices and the complementary five-helix fragment.

Authors:  T W Kahn; D M Engelman
Journal:  Biochemistry       Date:  1992-07-07       Impact factor: 3.162

2.  Membrane protein folding and oligomerization: the two-stage model.

Authors:  J L Popot; D M Engelman
Journal:  Biochemistry       Date:  1990-05-01       Impact factor: 3.162

3.  Effects of incorporated trypsin on anion exchange and membrane proteins in human red blood cell ghosts.

Authors:  S Lepke; H Passow
Journal:  Biochim Biophys Acta       Date:  1976-12-02

4.  Mediation of inorganic anion transport by the hydrophobic domain of mouse erythroid band 3 protein expressed in oocytes of Xenopus laevis.

Authors:  S Lepke; A Becker; H Passow
Journal:  Biochim Biophys Acta       Date:  1992-04-29

5.  Properties of detergents.

Authors:  A Helenius; D R McCaslin; E Fries; C Tanford
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  Anion transport in relation to proteolytic dissection of band 3 protein.

Authors:  S Grinstein; S Ship; A Rothstein
Journal:  Biochim Biophys Acta       Date:  1978-02-21

7.  Glycophorin A facilitates the expression of human band 3-mediated anion transport in Xenopus oocytes.

Authors:  J D Groves; M J Tanner
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

8.  Behavior of fragmented band 3 from chymotrypsin-treated bovine erythrocyte membrane in nonionic detergent solution.

Authors:  S Makino; H Nakashima
Journal:  J Biochem       Date:  1982-10       Impact factor: 3.387

9.  Detergent interaction with band 3, a model polytopic membrane protein.

Authors:  J R Casey; R A Reithmeier
Journal:  Biochemistry       Date:  1993-02-02       Impact factor: 3.162

10.  Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum.

Authors:  Y Fujiki; A L Hubbard; S Fowler; P B Lazarow
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

View more
  7 in total

1.  Topology studies with biosynthetic fragments identify interacting transmembrane regions of the human red-cell anion exchanger (band 3; AE1).

Authors:  J D Groves; M J Tanner
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Structural model for the organization of the transmembrane spans of the human red-cell anion exchanger (band 3; AE1).

Authors:  J D Groves; M J Tanner
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

3.  Transmembrane folding of the human erythrocyte anion exchanger (AE1, Band 3) determined by scanning and insertional N-glycosylation mutagenesis.

Authors:  M Popov; J Li; R A Reithmeier
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  Cysteine-directed cross-linking localizes regions of the human erythrocyte anion-exchange protein (AE1) relative to the dimeric interface.

Authors:  A M Taylor; Q Zhu; J R Casey
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

5.  Putative re-entrant loop 1 of AE2 transmembrane domain has a major role in acute regulation of anion exchange by pH.

Authors:  Andrew K Stewart; Christine E Kurschat; Richard D Vaughan-Jones; Seth L Alper
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

6.  The cytoplasmic domain is essential for transport function of the integral membrane transport protein SLC4A11.

Authors:  Sampath K Loganathan; Chris M Lukowski; Joseph R Casey
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-18       Impact factor: 4.249

Review 7.  Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Authors:  Doris Loh; Russel J Reiter
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.